登录 | 注册    关注公众号  
微信公众号
搜索
 > 【TNF-beta】

TNF-beta信息

英文名称:Tumor necrosis factor β
中文名称:肿瘤坏死因子β
靶点别称:TNF Superfamily Member 1,TNLG1E,LT,Lymphotoxin-alpha,TNFSF1,Tumor Necrosis Factor Ligand Superfamily Member 1,Tumor Necrosis Factor Beta,LT-alpha,LTA#TNFB,LTA,Lymphotoxin Alpha,TNF-Beta,TNFB,Lymphotoxin Alpha (TNF Superfamily, Member 1),Tumor Necrosis Factor Ligand 1E,Truncated Lymphotoxin Alpha,TNF Superfamily, Member 1
上市药物数量:15
临床药物数量:3
最高研发阶段:批准上市

TNF-beta分子别名

LTA,DAMA-25N12,13-004,LT,TNFB,TNFSF1,LT-alpha,TNF-beta

TNF-beta分子背景

The encoded protein, a member of the tumor necrosis factor family, is a cytokine produced by lymphocytes. The protein is highly inducible, secreted, and forms heterotrimers with lymphotoxin-beta which anchor lymphotoxin-alpha to the cell surface. This protein also mediates a large variety of inflammatory, immunostimulatory, and antiviral responses, is involved in the formation of secondary lymphoid organs during development and plays a role in apoptosis. Genetic variations in this gene are associated with susceptibility to leprosy type 4, myocardial infarction, non-Hodgkin's lymphoma, and psoriatic arthritis. Alternatively spliced transcript variants have been observed for this gene.

TNF-beta上市药物信息

英文名称 中文名称 研发代码 研发阶段 公司 最早商品名 最早批准国家 最早适应症 最早批准公司 最早批准日期 适应症 临床试验

TNF-beta临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验

消息提示

请输入您的联系方式,再点击提交!

确定